Non-invasive prediction of persistent villous atrophy in celiac disease

Table 1 Summary of patient characteristics at the time of biopsy on gluten-free diet

Characteristic	Category	All patients with celiac disease (n = 82)
		n	%
Gender	Female	67	81.7
	Male	15	18.3
Villous atrophy	No	63	76.8
	Yes	19	23.2
Marsh in follow-up biopsy	Marsh 0	44	53.7
	Marsh 1	19	23.2
	Marsh 3a	10	12.2
	Marsh 3b	4	4.9
	Marsh 3c	5	6.1
Autoantibodies aTTG	Negative	63	77.8
	Positive	18	22.2
	Unknown	1	1.2
Autoantibodies aDGP	Negative	49	62.8
	Positive	29	37.2
	Unknown	4	4.9
Diarrhea	No	62	75.6
	Yes	19	23.2
	Unknown	1	1.2
Weight loss	No	73	89.0
	Yes	8	9.8
	Unknown	1	1.2
Abdominal pain	No	64	78.0
	Yes	17	20.7
	Unknown	1	1.2
Anemia	No	71	86.6
	Yes	9	11.0
	Unknown	2	2.4
Sideropenia	No	58	70.7
	Yes	22	26.8
	Unknown	2	2.4
Vitamin D deficiency	No	63	76.8
	Yes	17	20.7
	Unknown	2	2.4
Ultrasonography	Negative	42	51.2
	Positive	24	29.3
	Unknown	16	19.5

aTTG: Anti-tissue transglutaminase antibodies; aDGP: Anti-deamidated gliadin peptide antibodies.